<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3C83A8CE-8C98-462F-BD2D-7E8E5B913716"><gtr:id>3C83A8CE-8C98-462F-BD2D-7E8E5B913716</gtr:id><gtr:name>Chirotech Technology</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:department>Sch of Chemistry</gtr:department><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3C83A8CE-8C98-462F-BD2D-7E8E5B913716"><gtr:id>3C83A8CE-8C98-462F-BD2D-7E8E5B913716</gtr:id><gtr:name>Chirotech Technology</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C60E100D-C10E-4549-91DF-1F37D2506831"><gtr:id>C60E100D-C10E-4549-91DF-1F37D2506831</gtr:id><gtr:name>Chirotech Technology Limited</gtr:name><gtr:address><gtr:line1>Unit 162, Cambridge Science Park</gtr:line1><gtr:line2>Milton Road</gtr:line2><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB4 0GH</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/344E4A51-0471-44FF-80E8-40E30D5D6C33"><gtr:id>344E4A51-0471-44FF-80E8-40E30D5D6C33</gtr:id><gtr:firstName>S</gtr:firstName><gtr:surname>Woodward</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=EP%2FE030092%2F1"><gtr:id>74F48C78-EA2C-4C71-9EA7-B60B36C85CDE</gtr:id><gtr:title>Achieving 1,4-Additions to 'Impossible' Substrates</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>EP/E030092/1</gtr:grantReference><gtr:abstractText>There are no examples of catalytic aymmetric 1,4-additions of Grignard reagents (RMgX) to unsaturated amides (Case 1) despite the high synthetic utility that this transformation would offer. Similarly, no catalytic addition of a diorganozinc species (ZnR2) to an unsaturated esters (Case 2) has ever been reported. In collaboration with DowPharma we have recently uncovered the first examples of these two transformations. We wish to carry out a highly focused proof of application study for these remarkable reactions.</gtr:abstractText><gtr:fund><gtr:end>2008-04-01</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/798CB33D-C79E-4578-83F2-72606407192C"><gtr:id>798CB33D-C79E-4578-83F2-72606407192C</gtr:id><gtr:name>EPSRC</gtr:name></gtr:funder><gtr:start>2007-04-02</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>94053</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Chirotech Technology</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Chirotech Technology Limited</gtr:description><gtr:id>C12B3669-2DC1-4123-AD2D-2ECC4347E794</gtr:id><gtr:outcomeId>b9c8ed6cb9c8ed80-1</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>2EB251DF-45F3-43EB-9F4E-E671FADC9D9F</gtr:id><gtr:title>In Search of New Approaches to Asymmetric Conjugate Addition: Screening Studies on the Use of [Zn(bpy*)X(R)] Reagents and a,?-Unsaturated Amide Michael Acceptors</gtr:title><gtr:parentPublicationTitle>Collection of Czechoslovak Chemical Communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5eadfa1b02e856b6361c52356066298b"><gtr:id>5eadfa1b02e856b6361c52356066298b</gtr:id><gtr:otherNames>Blake A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:outcomeId>doi_53d071071ad7bbb6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>50F3D0FF-1B86-4B98-94E4-799890794116</gtr:id><gtr:title>Rearrangement of beta-chloro N-oxides to hydroxylamines: opening of the oxazetidinium intermediate by different nucleophiles.</gtr:title><gtr:parentPublicationTitle>The Journal of organic chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2d4b57306234ca67bf19cfe1348a02ed"><gtr:id>2d4b57306234ca67bf19cfe1348a02ed</gtr:id><gtr:otherNames>Wefelscheid UK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-3263</gtr:issn><gtr:outcomeId>doi_55f95195129bd301</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1EDEACD6-ABA2-40C6-B7CA-C478E3BCC665</gtr:id><gtr:title>Sugar-phosphite-oxazoline and phosphite-phosphoroamidite ligand libraries for Cu-catalyzed asymmetric 1,4-addition reactions</gtr:title><gtr:parentPublicationTitle>Tetrahedron: Asymmetry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1ed41c6fb967be90e23bcc22f09db58b"><gtr:id>1ed41c6fb967be90e23bcc22f09db58b</gtr:id><gtr:otherNames>Mata Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:outcomeId>doi_53d00c00cfaaddee</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>084B38DB-2FE2-4A8D-AC74-864AC61CFB6E</gtr:id><gtr:title>Properties, Preparation and Synthetic Uses of Amine
 
 -Oxides. An Update</gtr:title><gtr:parentPublicationTitle>Organic Preparations and Procedures International</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6648742ab16d7d696d1adb807ab9542c"><gtr:id>6648742ab16d7d696d1adb807ab9542c</gtr:id><gtr:otherNames>Bernier D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:outcomeId>56bba753c7bbd4.75718744</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>639EAF39-8890-489D-9F27-B0E3205D1E5D</gtr:id><gtr:title>Asymmetric aryl addition to aldehydes</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/959d86030384567f49b5a5581c4f52f2"><gtr:id>959d86030384567f49b5a5581c4f52f2</gtr:id><gtr:otherNames>n/a Glynn</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:outcomeId>m_228640315113f27a48</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>75E6D06A-006C-41CF-99DF-466233E7AA84</gtr:id><gtr:title>Stereoselective 1,4-addition of Grignard reagents to a,?-enamides using a combined chiral auxiliary-catalyst approach</gtr:title><gtr:parentPublicationTitle>Tetrahedron: Asymmetry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c4e540fce0b37d4e71549c14e5099e9e"><gtr:id>c4e540fce0b37d4e71549c14e5099e9e</gtr:id><gtr:otherNames>Biswas K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:outcomeId>doi_53d00c00cfc88c7c</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">EP/E030092/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects><gtr:researchSubject><gtr:id>60EBB420-734E-4DB5-B0F2-65A1115A27F8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Chemical synthesis</gtr:text></gtr:researchSubject></gtr:researchSubjects><gtr:researchTopics><gtr:researchTopic><gtr:id>41B6965D-D659-4099-9434-7C61B7E5BEF2</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Asymmetric Chemistry</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>454398F2-57A6-4959-8845-0F248CF4D5C4</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Chemical Synthetic Methodology</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>